Literature DB >> 12714883

Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis.

Michael G Alexandrakis1, Freda H Passam, Ioanna A Moschandrea, Anna V Christophoridou, Constantina A Pappa, Stavroula A Coulocheri, Despina S Kyriakou.   

Abstract

Essential thrombocytosis (ET) is a myeloproliferative disorder resulting in an increased production of abnormal platelets. Reactive thrombocytosis (RT) is occasionally observed in clinical situations including chronic inflammation and malignancy. The aim of the present study was to evaluate the discriminatory efficiency of various laboratory tests in patients with ET and cancer-related RT. Forty-five patients with ET, 52 patients with RT, and 25 age-matched normal individuals comprised the study population. Plasma interleukin-1 alpha (IL-1a), IL-2, IL-6, tumor necrosis factor alpha (TNF-a), platelets, hematocrit, hemoglobin, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), lactate dehydrogenase (LDH) and ferritin were determined. We found increased levels of ferritin, LDH, CRP, ESR, IL-1a, and IL-6 in RT compared with ET (p < 0.01 to p < 0.0005). Hemoglobin, hematocrit, and platelets were significantly lower in RT than in ET (p < 0.0005). Furthermore, ferritin and ESR were negatively correlated with Hct, hemoglobin, and TNF-a, whereas ferritin was positively correlated with ESR, IL-1a, IL-6, and CRP, and IL-1a was positively correlated with IL-6. We consider that the aforementioned parameters should be included in the investigation of unexplained thrombocytosis for the differentiation of essential from cancer related thrombocytosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714883     DOI: 10.1097/00000421-200304000-00007

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  58 in total

Review 1.  Best practice in primary care pathology: review 3.

Authors:  W S A Smellie; J Forth; D Bareford; P Twomey; M J Galloway; E C M Logan; S R S Smart; T M Reynolds; C Waine
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

Review 2.  Thrombocytosis as a prognostic marker in gastrointestinal cancers.

Authors:  Ioannis A Voutsadakis
Journal:  World J Gastrointest Oncol       Date:  2014-02-15

3.  Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer.

Authors:  Jin Wang; Jinglei Qu; Zhi Li; Xiaofang Che; Jing Liu; Yuee Teng; Bo Jin; Mingfang Zhao; Yunpeng Liu; Xiujuan Qu
Journal:  J Clin Lab Anal       Date:  2017-02-26       Impact factor: 2.352

4.  Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients.

Authors:  Wei-wei Zhang; Ke-jun Liu; Guo-lin Hu; Wei-jiang Liang
Journal:  Tumour Biol       Date:  2015-06-11

5.  Comparison of platelet-lymphocyte ratio and CA 19-9 in differentiating benign from malignant head masses in patients with chronic pancreatitis.

Authors:  Shanavas Kakkat; Ramesh Rajan; R S Sindhu; Bonny Natesh; S Raviram
Journal:  Indian J Gastroenterol       Date:  2017-09-16

6.  Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction.

Authors:  Basem Azab; Neeraj Shah; Meredith Akerman; Joseph T McGinn
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

7.  Diagnostic Role of Platelet Lymphocyte Ratio(PLR) in Pancreatic Head Masses.

Authors:  Ripan K Miglani; Neeraj Bhateja; Ravi Shanker Bhat; K V Ashok Kumar
Journal:  Indian J Surg       Date:  2012-03-27       Impact factor: 0.656

8.  Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio.

Authors:  Richard A Smith; Paula Ghaneh; Robert Sutton; Michael Raraty; Fiona Campbell; John P Neoptolemos
Journal:  J Gastrointest Surg       Date:  2008-06-10       Impact factor: 3.452

Review 9.  Inflammation-based factors and prognosis in patients with colorectal cancer.

Authors:  Kiyoshi Maeda; Masatusne Shibutani; Hiroshi Otani; Hisashi Nagahara; Tetsuro Ikeya; Yasuhito Iseki; Hiroaki Tanaka; Kazuya Muguruma; Kosei Hirakawa
Journal:  World J Gastrointest Oncol       Date:  2015-08-15

10.  Elevated preoperative C-reactive protein levels are a risk factor for the development of postoperative infectious complications following elective colorectal surgery.

Authors:  Toru Kubo; Satoshi Ono; Hideki Ueno; Eiji Shinto; Junji Yamamoto; Kazuo Hase
Journal:  Langenbecks Arch Surg       Date:  2013-08-29       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.